A Prospective Study of Sacituzumab Tirumotecan Plus Pembrolizumab for Advanced Biliary Tract Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Prospective Study of Sacituzumab Tirumotecan Plus Pembrolizumab for Advanced Biliary Tract Cancer	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm	Recruiting	Phase 2	2026-10-05		NCT07850791

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Haitao Zhao, MD	4

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College	Beijing	China	6

Clinical trials